Manufacturer and exporter of castor oil and its derivatives, supplying industries from cosmetics and pharmaceuticals to paints, plastics and aerospace
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 310 | 366 | 451 | 492 | 527 | 562 | 574 | 595 |
| Borrowings | 182 | 166 | 149 | 94 | 159 | 110 | 191 | 131 |
| Other Liabilities | 113 | 131 | 170 | 167 | 172 | 182 | 163 | 241 |
| Total Liabilities | 621 | 678 | 785 | 769 | 873 | 869 | 943 | 982 |
| AssetsFixed Assets | 225 | 217 | 228 | 233 | 291 | 316 | 310 | 328 |
| CWIP | 18 | 19 | 12 | 36 | 20 | 6 | 18 | 10 |
| Investments | 10 | 11 | 11 | 12 | 12 | 13 | 13 | 11 |
| Other Assets | 367 | 431 | 534 | 488 | 550 | 535 | 603 | 633 |
| Total Assets | 621 | 678 | 785 | 769 | 873 | 869 | 943 | 982 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 170 | 344 | 40 | 65 | 115 | 16 | 118 | 44 |
| Cash from Investing | -6 | -28 | -6 | -17 | -41 | -53 | -28 | -34 |
| Cash from Financing | -163 | -313 | -36 | -35 | -81 | 36 | -93 | -6 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 158 | 311 | 34 | 47 | 74 | -38 | 90 | 10 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (14.4×) and current (14.1×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At -3.3% growth and a 14× exit, ₹220 only delivers your return if you pay ₹74. The price is currently baking in 18% growth.
EPS grows -3.3%/yr for 5 years, then fades to 6% over 2, exits at 14×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | -3.3% | 15.05 |
| FY28 | -3.3% | 14.55 |
| FY29 | -3.3% | 14.07 |
| FY30 | -3.3% | 13.61 |
| FY31 | -3.3% | 13.16 |
| FY32 | 1.3% ·fade | 13.33 |
| FY33 | 6.0% ·fade | 14.13 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.